Group 1 - Longqi Technology (SH 603341) announced on November 28 that Suzhou Shunwei has reduced its shareholding by approximately 19.19 million shares, accounting for 4.09% of the company's total equity, and no longer holds any shares as of the announcement date [1] - For the first half of 2025, Longqi Technology's revenue composition is as follows: smartphones account for 70.44%, AIoT products for 16.68%, tablets for 9.55%, and other businesses for 3.33% [1] - As of the announcement, Longqi Technology has a market capitalization of 19 billion yuan [1]

证券代码：603341 证券简称：龙旗科技 公告编号：2025-109 上海龙旗科技股份有限公司 关于股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 大股东持股的基本情况 本次减持计划实施前，上海龙旗科技股份有限公司（以下简称"公司"）股 东天津金米投资合伙企业（有限合伙）（以下简称"天津金米"）持有公司无限售 条件流通股 23,221,393 股，占公司总股本的 4.95%；苏州工业园区顺为科技创业 投资合伙企业（有限合伙）（以下简称"苏州顺为"）持有公司无限售条件流通股 19,191,600 股，占公司总股本的 4.09%。天津金米、苏州顺为系同一实际控制人 控制下的一致行动人，合计持有公司无限售条件流通股 42,412,993 股，占公司总 股本的 9.04%。 减持计划的实施结果情况 2025 年 9 月 2 日，公司在上海证券交易所网站（www.sse.com.cn）披露了《上 海龙旗科技股份有限公司关于股东减持股份计划公告》（公告编号：2025-093）， 具体减持计 ...

格隆汇11月28日｜龙旗科技(603341.SH)公告称，公司股东苏州工业园区顺为科技创业投资合伙企业 （有限合伙）已完成减持计划，累计减持公司股份1919.16万股，占公司总股本的4.09%，减持价格区间 为40.00-52.80元/股，减持总金额为8.67亿元。减持完成后，苏州顺为不再持有公司股份。 ...

格隆汇11月28日丨龙旗科技(603341.SH)公布，2025年11月28日，公司收到了天津金米、苏州顺为发来 的《关于所持上海龙旗科技股份有限公司股份减持结果告知函》。截至2025年11月27日，苏州顺为通过 集中竞价交易及大宗交易方式减持公司股份1919.16万股，占公司总股本的4.09%。截至本公告披露日， 苏州顺为不再持有公司股份，减持计划已实施完毕。 ...

龙旗科技公告，苏州工业园区顺为科技创业投资合伙企业（有限合伙）2025年9月24日～2025年11月27 日通过集中竞价减持1564.4万股、大宗交易减持354.76万股，合计减持1919.16万股，占公司总股本 4.09%，减持价格区间40～52.8元/股，套现8.67亿元，当前持股0股、持股比例0%，减持计划实施完 毕。 ...

Core Viewpoint - Longqi Technology (龙旗科技) is actively investing in the embodied intelligence industry by participating in a venture capital fund, aiming to enhance its competitive strength and secure quality investment targets [2]. Group 1: Investment Activities - Longqi Technology's wholly-owned subsidiary, Longqi Intelligent, plans to invest 30 million yuan in the Shanghai Lingzhi New Venture Capital Partnership, accounting for 23.08% of the total committed capital [2]. - The partnership will focus on direct or indirect equity investments in innovative companies related to the embodied intelligence industry, including key materials, components, software systems, and robotics applications [2]. Group 2: Business Development - As a leading ODM in smart products, Longqi Technology provides comprehensive services to major global consumer electronics brands, including Xiaomi, Samsung, and Lenovo, with a product portfolio that includes smartphones, tablets, smartwatches, and automotive electronics [3]. - The company is expanding into emerging categories such as automotive electronics and intelligent robotics, with a strategic partnership with Zhiyuan Robotics to deploy nearly 1,000 robots in industrial applications, marking one of the largest orders in the domestic market [3]. Group 3: AI Hardware Breakthroughs - Longqi Technology has achieved significant advancements in AI glasses and AI PCs, with the first smart glasses project entering mass production and two new AI PC products launched [4]. - The revenue from AIoT products reached 2.282 billion yuan in Q3 2025, representing a year-on-year growth of over 47%, and accounting for 20% of the company's total revenue [4].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603341 证券简称：龙旗科技 公告编号：2025-108 上海龙旗科技股份有限公司关于全资子公司参与认购投资基金份额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、合作情况概述 （一）合作的基本概况 龙旗智能于2025年11月24日与其他各方共同签署了《上海瓴智新创创业投资合伙企业（有限合伙）合伙 协议》。为了借助专业投资机构的资源及投资经验，储备更多的优质标的，进一步提升公司竞争实力， 龙旗智能参与认购合伙企业的基金份额。该合伙企业为创业投资基金，原则上投早投小，将主要对具身 智能产业链相关的创新企业进行直接或间接的股权投资、准股权投资或从事与投资相关的活动，包括但 不限于上游关键原材料及零部件，如伺服系统、电机、控制器、减速器、传感器等；关键软件系统及人 工智能算法等；中游机器人本体制造与集成，及机器人下游应用解决方案等。龙旗智能作为有限合伙人 以自有资金认缴出资人民币3,000万元，占认缴出资总额的23.08%，合伙企业的经营期限 ...

证券日报网讯龙旗科技（603341）11月24日在互动平台回答投资者提问时表示，为保障信息披露的公平 原则，公司会在定期报告中依据相关法律法规披露股东人数以保证所有投资者平等获悉公司信息。 ...

Group 1: Financial Products and Investment Performance - The issue of inflated returns on bank wealth management products has gained significant attention, with many investors reporting discrepancies between advertised and actual returns [1] - Industry experts call for standardized performance displays and emphasize the need for investors to develop a more professional and rational understanding of performance benchmarks [1] - Liang Hong, a prominent private equity manager, publicly apologized for underperforming against major indices, attributing the decline to three main factors: heavy investments in innovative drugs, hardware companies, and stablecoin stocks [1][2] Group 2: Robotics and Electric Vehicles - The Ministry of Industry and Information Technology announced the establishment of a standardization committee for humanoid robots, with representatives from several listed companies included [2] - According to TrendForce, global sales of new energy vehicles reached 5.39 million units in Q3 2025, marking a 31% year-on-year increase, with battery electric vehicles (BEVs) growing by 48% [2] Group 3: Corporate Developments and Investments - Tuozhu denied reports of Tencent's investment in its latest funding round, stating that no current financing is taking place [3] - Jiangxi Changyun announced plans to publicly transfer land use rights and assets for 7.787 million yuan [5] - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund focused on the intelligent industry [6] - Jusaylong intends to increase its subsidiary's capital by 170 million yuan through a debt-to-equity swap [7] - ST Sansheng received 254 million yuan from restructuring investors [8] - Lege Co., Ltd. plans to repurchase shares worth 40 to 80 million yuan [9] - Petty Co., Ltd. announced a share buyback plan of 50 to 70 million yuan [11] Group 4: Market Performance - The market showed a rebound with all major indices closing in the green, driven by strong performances in the aerospace, military, and AI application sectors [15] - The total trading volume in the Shanghai and Shenzhen markets was 1.73 trillion yuan, reflecting a decrease from the previous trading day [15]

Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]